logo

For the Inventor, By the Inventor

Gothenburg, Sweden

Bengt Arne Ablad

This inventor holds 4 USPTO granted patents. Top assignee: Aktiebolaget Hassle. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bengt Arne Ablad. Retrieved from https://idiyas.com/inventor/bengt-arne-ablad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Goteborg, SE (1976)
  • Goteborg, S (1976)
  • Goteborg C, SE (1977 - 1978)

Company Filing History:

goldMedal4 out of 69 
 
Aktiebolaget Hassle
 patents

Years Active: 1976-1978

Loading Chart...
4 patents (USPTO):Explore Patents
1. 4078146 - Phenoxy propanolamines (1978-03-07),
2. 4035420 - Substituted ureido alkylene phenoxy propanolamines (1977-07-12),
3. 3998790 - Phenoxy-hydroxypropylamines, their preparation, and method and (1976-12-21),
4. 3996382 - Phenoxy-hydroxypropylamines, their preparation, and method and (1976-12-07),

Title: The Innovations of Bengt Arne Ablad

Introduction

Bengt Arne Ablad is a notable inventor based in Goteborg C, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new amines for cardiovascular treatment. With a total of 4 patents, Ablad's work has the potential to impact medical practices significantly.

Latest Patents

Ablad's latest patents include innovative compounds such as phenoxy propanolamines. These new amines are characterized by the formula ##STR1##, where the radicals R.sup.1, R.sup.2, and R.sup.3 can be various groups. These compounds are particularly useful in treating cardiovascular diseases by blocking cardiac and vascular beta-receptors. Another significant patent involves substituted ureido alkylene phenoxy propanolamines, which share a similar formula and application in cardiovascular treatment.

Career Highlights

Bengt Arne Ablad has been associated with Aktiebolaget Hassle, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work focuses on creating effective treatments for cardiovascular conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Ablad has collaborated with notable colleagues, including Peder Bernhard Berntsson and Arne Elof Brandstrom. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Bengt Arne Ablad's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cardiovascular treatments, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…